Anti-CD44 / HCAM Std. Antibody (HCAM/918)

Anti-CD44 / HCAM Std. Antibody (HCAM/918)is available at Gentaur for Next week Delivery.

Description: Recognizes a cell surface glycoprotein of 80-95 kDa (CD44) on lymphocytes, monocytes, and granulocytes. Its epitope is resistant to digestion by trypsin and chymotrypsin. The CD44 family of glycoproteins exists in a number of variant isoforms, the most common being the standard 85-95 kDa or hematopoietic variant (CD44s). Higher molecular weight isoforms are described in epithelial cells (CD44v), which are believed to function in intercellular adhesion and stromal binding. CD44 immunostaining is commonly used for the discrimination of urothelial transitional cell carcinoma in-situ from non-neoplastic changes in the urothelium.

Immunogen Sequence:Recombinant human HCAM protein

Target Alternative Name:LHR; BA-1; chondroitin sulfate proteoglycan 8 (CSPG8); Epican; Extracellular Matrix Receptor III (ECM III); GP90 Lymphocyte Homing Adhesion Receptor; HCAM; HCELL; hematopoietic cell E- and L-selectin ligand; Heparan Sulfate Proteoglycan; Hermes Antigen; HAS; HUTCH I; Hyaluronate Receptor; Indian blood group; Inlu Related p80 Glycoprotein; Ly 24; MDU2; MDU3; MIC4; MUTCH I; Phagocytic Glycoprotein 1 (PGP-1)

Species Reactivities:Human and non-human Primates

Tag Line:Monoclonal Antibody to detect CD44 / HCAM Std. in human and non-human Primates samples

Formulation:In 10 mM PBS with 0.05% BSA & 0.05% azide

Purification: Protein A/G purification

Application:FC, IF, IHC

Positive Control:IHC: Breast Carcinoma, WB: DU145 Cell Lysate

Application And Usages:FC: 0.5-1 µg/1X106 cells in 0.1ml, IF: 0.5-1 µg/ml, IHC: 0.25-0.5 µg/ml for 30 minutes at RT

Handling:The antibody solution should be gently mixed before use